» Articles » PMID: 23333709

Bottom-up Approaches for Preparing Drug Nanocrystals: Formulations and Factors Affecting Particle Size

Overview
Journal Int J Pharm
Specialties Chemistry
Pharmacology
Date 2013 Jan 22
PMID 23333709
Citations 95
Authors
Affiliations
Soon will be listed here.
Abstract

The solubility dependent bioavailability problem has become a major hurdle in drug development processes. Drug nanocrystals have been widely accepted by the pharmaceutical industry to improve the bioavailability of poorly water-soluble compounds. Top-down and bottom-up technologies are the two primary technical approaches of drug nanocrystal production. Though the top-down approach has been hugely successful on the commercial front, it has some inherent drawbacks that necessitate the emergence of alternate approaches. The bottom-up approach has not yet been established as a successful commercial technology. However, it has the potential to produce small size drug nanocrystals with less energy demanding processes. The bottom-up approach is commonly known as precipitation technique. It would be possible to stabilize particles at an early stage of precipitation and to generate drug nanocrystals. In the first part of this review article, we have discussed various bottom-up technologies that are currently in use. This has been followed by description and analysis of various process parameters that can affect the final particle size of the drug nanocrystals.

Citing Articles

Nanosuspension Innovations: Expanding Horizons in Drug Delivery Techniques.

Jacob S, Kather F, Boddu S, Attimarad M, Nair A Pharmaceutics. 2025; 17(1).

PMID: 39861782 PMC: 11768797. DOI: 10.3390/pharmaceutics17010136.


Strategies to Enhance Nanocrystal Formulations for Overcoming Physiological Barriers Across Diverse Routes of Administration.

Yanamadala Y, Muthumula C, Khare S, Gokulan K Int J Nanomedicine. 2025; 20():367-402.

PMID: 39816376 PMC: 11733173. DOI: 10.2147/IJN.S494224.


Advancing Therapeutic Strategies with Polymeric Drug Conjugates for Nucleic Acid Delivery and Treatment.

Ullah A, Khan M, Zhang Y, Shafiq M, Ullah M, Abbas A Int J Nanomedicine. 2025; 20():25-52.

PMID: 39802382 PMC: 11717654. DOI: 10.2147/IJN.S429279.


Nanocrystals in Dermal Drug Delivery: A Breakthrough for Enhanced Skin Penetration and Targeted Skin Disorder Treatments.

Alnaim A Pharmaceutics. 2025; 16(12.

PMID: 39771540 PMC: 11676127. DOI: 10.3390/pharmaceutics16121561.


Development of Dermal Lidocaine Nanosuspension Formulation by the Wet Milling Method Using Experimental Design: In Vitro/In Vivo Evaluation.

Kral O, Ilbasmis-Tamer S, Han S, Tirnaksiz F ACS Omega. 2025; 9(52):50992-51008.

PMID: 39758633 PMC: 11696440. DOI: 10.1021/acsomega.4c05296.